Cyclacel
Research & Development

Overview

Cyclacel is a biopharmaceutical pioneer developing small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases, particularly those of high unmet medical need. Our vision is to improve patient healthcare with innovative medicines.

We have generated several anticancer drugs that act on the cell cycle including CYC065, CYC140 and CYC682 (Sapacitabine). These drugs are currently under clinical investigation.

Development Pipeline

Development Pipeline diagram

* Please refer to the Corporate Factsheet for further information.


Research & Development